Publications in collaboration with researchers from Hospital Universitario de la Princesa (22)

2024

  1. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

    Multiple Sclerosis and Related Disorders, Vol. 90

  2. Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 84

  3. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I)

    Revista de neurologia, Vol. 79, Núm. 1, pp. 21-29

  4. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)

    Revista de neurologia, Vol. 79, Núm. 2, pp. 51-66

2023

  1. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

    PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441

  2. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  3. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2022

  1. Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 8, Núm. 4

  2. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

  3. Sick leave and occupational burnout among nurses caring for patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 63

2021

  1. Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain

    PLoS ONE, Vol. 16, Núm. 12 December

  2. Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry

    PLoS ONE, Vol. 16, Núm. 10 October

  3. Plasma determination of neurofilaments as biomarkers in multiple sclerosis: Conclusions of the EMotion Forum

    Revista de Neurologia, Vol. 73, Núm. 3, pp. 101-110

  4. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol

    Frontiers in Neurology, Vol. 12

2020

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Neurologia, Vol. 35, Núm. 3, pp. 185-206

2019

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Medicina Clinica, Vol. 153, Núm. 2, pp. 82.e1-82.e17

2018

  1. Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to over-expression of mutated huntingtin

    Journal of Neurochemistry, Vol. 147, Núm. 4, pp. 454-476

  2. Dual antidepressant duloxetine blocks Nicotinic receptor currents, calcium signals and exocytosis in chromaffin cells stimulated with acetylcholine

    Journal of Pharmacology and Experimental Therapeutics, Vol. 367, Núm. 1, pp. 28-39

  3. Hydrogen sulphide facilitates exocytosis by regulating the handling of intracellular calcium by chromaffin cells

    Pflugers Archiv European Journal of Physiology, Vol. 470, Núm. 8, pp. 1255-1270

2016

  1. Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis

    PLoS ONE, Vol. 11, Núm. 8